Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis

This study shows different metabolic effects, including detailed lipid modulations, from genetic inhibition of ANGPTL3 in comparison to ANGPLT4 and LPL.